Reportlinker Adds R&D Trends: disease of the skin - Pipeline mindset following ... Pr Newswire (press release) The Psoriasis region and Severity scale of measurement (PASI) remains the gold standard tool for efficacy, owed to historic utilization and ease of benchmarking new and existing therapies. state of matter III trials similar Stelara versus Enbrel lead dermatologists to speculate that ... and more » Link To Article
No comments:
Post a Comment